4BASEBIO UK SOCIETAS

Here is the public summary page for 4BASEBIO UK SOCIETAS. Please login to see the complete information for 4BASEBIO UK SOCIETAS including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how 4BASEBIO UK SOCIETAS stacks up relative to its peers.


Darwin Score-14
Ticker4BB
Latest Price9.00 GBP as of close on 15-Aug-2025
3 Month price range9.00 to 11.25 GBP
Market Capitalisation139.36Mn GBP
CountryUK
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5' and 3' ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccines and therapeutics; and oeDNA, or open ended DNA, a linear, double stranded DNA product ideal for genome editing. It also provides osDNA, or open stabilized DNA, a product incorporating nucleotide modifications within the DNA backbone enables tuning of the immunostimulatory properties of the construct for DNA vaccine applications; and The Hermes, a proprietary delivery platform for nucleic acid and protein payloads appears to offer a thermo-stable alternative to traditional lipid based delivery systems. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
See More ...
Company URLhttps://www.4basebio.com
See Darwins Full Analysis for 4BASEBIO UK SOCIETAS

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for 4BASEBIO UK SOCIETAS. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages-8
SentimentNews and Candle Patterns. +1
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.0
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-7

Alerts

There are 15 live alerts for 4BASEBIO UK SOCIETAS.


Peer Comparison

There are 29 peers of 4BASEBIO UK SOCIETAS.
Asset NameIndustry GroupPerf(20d)%Asset Score
Abingdon Health Plc (ABDX)Biotechnology0-25
Alliance Pharma plc (APH)Biotechnology+0.8+31
Angle PLC (AGL)Biotechnology-15.4-18
Aptamer Group PLC (APTA)Biotechnology+80.3+12
Arecor Therapeutics PLC (AREC)Biotechnology+29.6+6
Avacta Group PLC (AVCT)Biotechnology+47.7+16
BSF Enterprise Plc (BSFA)Biotechnology+1.2-16
Benchmark Holdings Plc (BMK)Biotechnology-10.7-18
Beximco Pharmaceuticals Limited (BXP)Biotechnology+20.3+32
BiVictriX Therapeutics PLC (BVX)Biotechnology+21.2+2
Bioventix (BVXP)Biotechnology-15.6+2
Celadon Pharmaceuticals PLC (CEL)Biotechnology0-8
Chill Brands Group PLC (CHLL)Biotechnology-2.3-21
Cizzle Biotechnology Holdings PLC (CIZ)Biotechnology-18.8-15
Destiny Pharma PLC (DEST)Biotechnology-7.7-30
Diaceutics PLC (DXRX)Biotechnology+7.0+17
Evgen Pharma PLC (EVG)Biotechnology-8.6-7
Faron Pharmaceuticals Oy (FARN)Biotechnology+2.4+12
Genflow Biosciences plc (GENF)Biotechnology-10.7-27
Genincode PLC (GENI)Biotechnology-26.3-21
Genus PLC (GNS)Biotechnology+8.3+20
Haleon PLC (HLN)Biotechnology0+4
Ondine Biomedical Inc (OBI)Biotechnology+25.0+14
Oxford BioMedica PLC (OXB)Biotechnology+33.6+41
Oxford Nanopore Technologies PLC (ONT)Biotechnology+43.5+8
Physiomics PLC (PYC)Biotechnology-10.5-9
Shield Therapeutics PLC (STX)Biotechnology+59.2+20
e-therapeutics plc (ETX)Biotechnology-28.0-4
genedrive plc (GDR)Biotechnology-39.3-8

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn